Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Aasly

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Parkinsonism & Related Disorders|July 24, 2021
Urine levels of the polyglutamine ataxin-3 protein are elevated in patients with spinocerebellar ataxia type 3Yuka Koike, Karen R Jansen-West, Rana Hanna Al-Shaikh, et al.
Annals of Neurology|January 5, 2022
Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation CarriersGian Pal, Graziella Mangone, Emily J Hill, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|May 21, 2011
Novel pathogenic mutations and copy number variations in the VPS13A gene in patients with chorea-acanthocytosisAkiyuki Tomiyasu, Masayuki Nakamura, Mio Ichiba, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 6, 2014
Michael J. Fox Foundation LRRK2 Consortium: geographical differences in returning genetic research data to study participantsRoy N Alcalay, Jan Aasly, Daniela Berg, et al.
Neurobiology of Aging|December 29, 2009
A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's diseaseRejko Krüger, Manu Sharma, Olaf Riess, et al.
Nature Genetics|December 27, 2011
Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroidsRosa Rademakers, Matt Baker, Alexandra M Nicholson, et al.
NPJ Parkinson'S Disease|June 7, 2024
Genome-wide determinants of mortality and motor progression in Parkinson's diseaseManuela M X Tan, Michael A Lawton, Miriam I Pollard, et al.
Annals of Neurology|March 11, 2011
Independent and joint effects of the MAPT and SNCA genes in Parkinson diseaseAlexis Elbaz, Owen A Ross, John P A Ioannidis, et al.
NPJ Parkinson'S Disease|March 30, 2024
Genotype-phenotype correlation in PRKN-associated Parkinson's diseasePoornima Jayadev Menon, Sara Sambin, Baptiste Criniere-Boizet, et al.
Neurology|October 19, 2014
Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson diseaseJessie Theuns, Aline Verstraeten, Kristel Sleegers, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Parkinsonism & Related Disorders|July 24, 2021
Urine levels of the polyglutamine ataxin-3 protein are elevated in patients with spinocerebellar ataxia type 3Yuka Koike, Karen R Jansen-West, Rana Hanna Al-Shaikh, et al.
Annals of Neurology|January 5, 2022
Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation CarriersGian Pal, Graziella Mangone, Emily J Hill, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|May 21, 2011
Novel pathogenic mutations and copy number variations in the VPS13A gene in patients with chorea-acanthocytosisAkiyuki Tomiyasu, Masayuki Nakamura, Mio Ichiba, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 6, 2014
Michael J. Fox Foundation LRRK2 Consortium: geographical differences in returning genetic research data to study participantsRoy N Alcalay, Jan Aasly, Daniela Berg, et al.
Neurobiology of Aging|December 29, 2009
A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's diseaseRejko Krüger, Manu Sharma, Olaf Riess, et al.
Nature Genetics|December 27, 2011
Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroidsRosa Rademakers, Matt Baker, Alexandra M Nicholson, et al.
NPJ Parkinson'S Disease|June 7, 2024
Genome-wide determinants of mortality and motor progression in Parkinson's diseaseManuela M X Tan, Michael A Lawton, Miriam I Pollard, et al.
Annals of Neurology|March 11, 2011
Independent and joint effects of the MAPT and SNCA genes in Parkinson diseaseAlexis Elbaz, Owen A Ross, John P A Ioannidis, et al.
NPJ Parkinson'S Disease|March 30, 2024
Genotype-phenotype correlation in PRKN-associated Parkinson's diseasePoornima Jayadev Menon, Sara Sambin, Baptiste Criniere-Boizet, et al.
Neurology|October 19, 2014
Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson diseaseJessie Theuns, Aline Verstraeten, Kristel Sleegers, et al.
Pageof 8